Search results

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors and platform users and collaborators safe and minimise the risk of the spread of COVID-19 infection.

The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.

Stage 1 of the Stawell Underground Physics Laboratory was officially opened today. It will be home to multi-disciplinary scientists from five research partners who help us understand dark matter.

Challenge your understanding of nuclear science and technology with fun secondary school activities, exciting competitions and unique tours of our facilities.

ANSTO can analyse minute amounts of organic or inorganic matter embedded in a complex material

Virtual activities celebrating the benefits of nuclear science and technology held for National Science Week

A new study by researchers from Curtin University using the infrared (IR) and X-ray fluorescence microscopy (XFM) beamlines at the Australian Synchrotron has provided a better understanding of the chemical and elemental composition of latent fingermarks.

ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.

Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape

Meeting of minds about potential next-generation cancer treatment for Australians

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

Lutetium-177 used for advanced prostate cancer

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.